1. Identify recent FDA drug communications, including but not limited to, labeling changes, warnings, new indications, new dosage forms and MedWatch alerts.
2. Discuss the new drugs with respect to their pharmacology, pharmacokinet- ics, approved and unapproved indications.
3. Describe their adverse effects and drug interaction that may affect patient compliance.